XPEV
Xpeng Inc
$13.66
▲ 4.4%Updated Today 12:11 PM ET
XPEV at a glance — five pillars scored 0–100 from real filed financials.
Overall: Weak · 39/100. A wider, greener shape means more pillars look healthy. Dividends scores 0 when a company pays none — that is a choice, not a flaw.
▼ Down 28.1% over the last 12 months
Market Cap
$13.04B
P/E
—
Forward P/E (est.)
—
ROE
-7.6%
Revenue Growth
47.5%
EPS Growth
—
Profit Margin
-3.1%
FCF Yield
—
Debt / Equity
1.12x
ROIC
-10.0%
Interest Coverage
—
Current Ratio
5.06x
Dividend Yield
—
Implied Growth (rev. DCF)
—
Rating Score
39/100
Xpeng Inc (XPEV) is a large-cap company in the Automobiles industry, part of the Consumer Discretionary sector of the S&P 500, with a market value around $13.04B.
In its latest reported year it generated about $895.68M in revenue and posted a net loss of $418.70M.
Our model rates XPEV Weak (39/100) on growth, profitability, financial health, and valuation. The summary below is built from its filed financials and current ratios and refreshes automatically.
Technical analysis reads price and volume to judge momentum and timing. It complements the fundamentals above — it does not replace them. Here is what XPEV's chart says today, with each tool explained.
Trend — moving averages. A moving average is the average closing price over a window, which smooths out daily noise. XPEV trades near $13.66, below its 50-day average ($15.19) and 200-day average ($18.82). Price below both averages is a downtrend — momentum is against buyers for now.
Momentum — RSI. The Relative Strength Index runs 0–100 and measures how strong recent gains are versus losses. Above 70 is "overbought", below 30 "oversold". At 41 it is in neutral territory — neither stretched nor washed out.
MACD. MACD compares two moving averages to flag shifts in momentum. Its histogram is currently positive — short-term momentum is improving.
Volatility — ATR. Average True Range is the typical daily move. XPEV's is $0.57 (~4.2% of price), so swings of about that size each day are normal — handy for setting a stop that isn't too tight.
Support & resistance. Over the last month XPEV found buyers near $11.77 (support) and sellers near $16.60 (resistance); its 52-week range is $11.77–$28.24. A decisive break beyond either edge often marks the next move.
Volume. The latest session traded 0.6× the 20-day average — lighter than usual, so the move carries less conviction. Rising volume on up-days suggests real buying; on down-days, real selling.
Educational information to help you read a chart — not a recommendation or a forecast. It updates daily as the price and indicators change.
1Y CAGR
0.0%
Revenue moved from $895.68M in 2020 to $895.68M in 2020. The most recent year grew a strong 47.5% year over year. Consistent top-line growth is one sign of healthy demand.
Gross Margin
4.6%
Operating Margin
-73.5%
Net Margin
-46.7%
ROE
-7.6%
Xpeng Inc keeps about -3.1% of each sales dollar as net profit, with a 4.6% gross margin and -73.5% operating margin. Return on equity is -7.6% and return on invested capital about -10.0%. The company is currently unprofitable on a net basis.
Total Debt
$150.00M
Net Debt
-$4.33B
Net cash position
Net Debt / EBITDA
—
Debt / Equity
1.12x
Leverage: debt-to-equity is 1.1x, with a current ratio of 5.1x. That is a moderate, manageable debt load for most businesses. It carries roughly $150.00M of total debt against $4.48B of cash.
Operating CF
-$21.42M
Free Cash Flow
-$144.96M
FCF Margin
-16.2%
In the latest year Xpeng Inc produced about -$21.42M of operating cash flow but negative free cash flow as it invested heavily. Cash flow is what ultimately pays shareholders, so it is worth tracking over time.
P/E
—
P/S
1.05x
P/B
4.35x
EV / EBITDA
—
XPEV trades at n/a trailing earnings, 1.0x sales, and 4.4x book value. With no positive trailing earnings, value it on sales, cash flow, or growth rather than P/E.
Where this stock sits versus what most companies trade at.
Typical ranges are general references (e.g., many stocks trade at ~18–26x earnings), not hard rules. Context only — not investment advice.
The case for XPEV:
- Revenue is growing 47.5% a year, a sign of real demand.
- As an established S&P 500 member in Consumer Discretionary, it brings scale and a long operating history.
The case against XPEV:
- Thin net margins (-3.1%) leave little room for error.
- Our model's overall read is Weak (39/100).
Balance-sheet risk — debt/equity of 1.1x magnifies the impact of higher rates or weaker earnings.
Margin risk — thin profitability (-3.1%) is vulnerable to cost or pricing pressure.
Market risk — sector rotation, the economic cycle, and broad sentiment move the stock regardless of fundamentals.
On balance, the fundamentals screen weakly: Xpeng Inc is a large-cap consumer discretionary business still growing nicely, with modest profitability, and a heavier debt load to watch. It trades at n/a earnings, which our model scores Weak (39/100). Weigh this against your own goals and time horizon — this is educational information, not a recommendation.
XPEV — frequently asked questions
Is XPEV a good stock to buy?
We don't give buy or sell advice. Our model rates Xpeng Inc Weak (39/100) based on its growth, profitability, financial health, and valuation — use that as a research starting point and make your own decision.
What is XPEV's rating on The Stocks School?
Xpeng Inc currently scores 39/100 (Weak) on our transparent model, which weighs real fundamentals: growth, margins, returns on capital, balance-sheet strength, and valuation.
How our ratings work →Where does XPEV's data come from?
Live price data plus real fundamentals and 5-year financials pulled directly from Xpeng Inc's SEC filings — refreshed automatically, not hand-entered.
How is the 5-year projection for XPEV calculated?
It's a scenario model: it grows revenue at an assumed rate, applies a profit margin and a valuation multiple, and shows the resulting share-price range. The assumptions are yours to change — it's a tool for thinking, not a prediction.
Is this XPEV analysis financial advice?
No. Everything on this page is educational research, not financial advice or a recommendation to buy or sell XPEV. Always do your own research and consider a licensed professional.
Data notice. Fundamentals and financial statements are sourced from company filings (SEC EDGAR) and market-data providers; prices and market caps refresh on trading days and may be delayed. Ratings, projections, technical signals, and written summaries are model- or rule-generated for education and may simplify or lag the latest filings.
Not advice. Nothing on this page is investment advice or a recommendation to buy, hold, or sell any security. Do your own research and consult a licensed financial professional before investing.